Parsonage-Turner syndrome: the nerve is recovering, so why is the pain staying?

A sudden, savage shoulder pain, then weakness that takes months to lift. For many people the pain outlives the nerve injury. Here is why.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

What Parsonage-Turner syndrome is

Parsonage-Turner syndrome (neuralgic amyotrophy, or brachial neuritis) is an inflammation of the brachial plexus, the bundle of nerves running from the neck through the shoulder into the arm. It usually begins with sudden, intense pain in the shoulder or upper arm, often at night, lasting days to weeks. As the pain eases, weakness appears in the shoulder and arm muscles, and some muscles shrink (atrophy). Numbness or tingling is common. The cause is unknown; it sometimes follows an infection, vaccination, surgery or intense exercise, and is thought to involve an immune reaction against the nerves.

Diagnosis is based on the characteristic story, examination, and nerve conduction and EMG studies; MRI may be used to exclude other causes such as a cervical disc problem or rotator cuff tear. Treatment is mainly supportive: pain relief in the acute phase, sometimes steroids early on, and physiotherapy to maintain movement and rebuild strength as the nerves recover.

The neuroplastic contribution

The ATNS Index of Neuroplastic Symptoms says evaluation for neuroplastic symptoms is reasonable as part of a complete assessment of Parsonage-Turner syndrome, particularly if the symptoms, the course over time or the response to treatment are not typical or as expected.

Neuroplastic symptoms are real symptoms produced by learned pathways in the brain and nervous system, a sensitized alarm system, rather than by ongoing damage in the nerve itself. They are not imaginary and not weakness of character, and because the brain can change, they are reversible. Parsonage-Turner is a particularly understandable setting for them:

• The acute pain is among the most severe in medicine. An experience that intense teaches the nervous system, fast and deeply, that the arm is dangerous.
• Nerve injury produces months of abnormal signals, which can leave the spinal cord and brain sensitized after the nerve has regrown.
• Weakness and wasting are frightening. Fear about permanent disability keeps the system in threat mode.
• Guarding the arm, avoiding use, and bracing the shoulder add tension and keep the pain pathway active.

The signal that this is happening is pain or fatigue that does not match the nerve recovery: the EMG improves, the strength returns, and the pain stays. Learning the difference between hurt and harm is especially helpful at that stage.

What the research shows

A Dutch study of long-term pain, fatigue and impairment in neuralgic amyotrophy surveyed 89 patients around two years after onset. Roughly a quarter to a third reported significant ongoing pain and fatigue, and between half and two-thirds still had limitations in daily life. The key finding for this article: pain and fatigue did not correlate with residual weakness. The symptoms were persisting independently of how much the nerve had recovered.

A systematic review pooling 25 studies and about 950 patients found residual neuropathic pain in around 60 percent and incomplete motor recovery in around 70 percent at follow-up of five to 25 months. The authors note that outcomes are worse than older teaching suggested, and that long-term follow-up is poorly reported. Their figures are from mixed follow-up periods, so they should be read as approximate.

A prospective primary-care cohort estimated the incidence at about one per thousand people per year, far higher than previously thought, suggesting many cases go unrecognised. This matters because an unrecognised nerve injury that was treated as a frozen shoulder or rotator cuff problem leaves people with no explanation, and uncertainty itself feeds sensitization.

None of these studies tested a brain-based treatment, so the neuroplastic contribution in Parsonage-Turner is inferred from the pattern (pain not tracking nerve recovery) and from the general science of central sensitization after nerve injury, rather than demonstrated directly.

Signs the nervous system may be part of the picture

• Strength and nerve studies are improving, but pain is not.
• Pain has spread beyond the original nerve distribution, to the neck, chest, back or other arm.
• Pain flares with stress, poor sleep or emotional strain more than with use.
• Fatigue is out of proportion to the physical effort you are doing.
• You are afraid to use the arm and keep it protected even when cleared to move.

A solution that addresses it

There is an approach that works on the brain's contribution to pain after nerve injury. Often called pain reprocessing, it combines education about neuroplastic symptoms, somatic tracking (observing arm and shoulder sensations with curiosity rather than fear), reducing threat around using the arm, a graded return to activity, emotional awareness and expression, and acceptance and commitment skills. Trained clinicians deliver it, and it is increasingly available through digital programs. It is an addition to neurology follow-up and physiotherapy, not a replacement, and it is most relevant once nerve recovery is underway and pain has stopped tracking it.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If your pain has outlasted your nerve injury, you can join the waitlist. For the science of a sensitized system, see why chronic pain persists.

What to do next

First, make sure the diagnosis is confirmed and the nerve recovery is being monitored. Nerve conduction studies and EMG track regrowth; MRI excludes other causes. Follow your physiotherapy plan and keep taking prescribed medication, including any nerve pain medicines, unless your clinician advises a change.

Second, if your pain or fatigue is not following the nerve recovery, ask your neurologist or pain clinician whether a sensitized nervous system could be contributing. This is the assessment the ATNS index describes.

Third, if it fits, start practising. Use the arm gradually with pacing, reduce guarding, address fear directly, and work on sleep.

Seek prompt medical attention for rapidly worsening weakness, weakness spreading to the other arm or the legs, trouble breathing (the diaphragm nerve can be involved), or new numbness in the saddle area or bladder or bowel changes.

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.